Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "collaborations"

178 News Found

Cabinet approves post of director for National Institute for One Health
Policy | March 02, 2024

Cabinet approves post of director for National Institute for One Health

The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness


India implementing largest digital programme for TB surveillance
News | February 24, 2024

India implementing largest digital programme for TB surveillance

Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi


Healthcare Triangle unveils new SaaS Solutions to drive AI integration in healthcare
Digitisation | February 16, 2024

Healthcare Triangle unveils new SaaS Solutions to drive AI integration in healthcare

The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations


BenevolentAI appoints former Bayer R&D head Dr. Joerg Moeller as CEO
People | January 25, 2024

BenevolentAI appoints former Bayer R&D head Dr. Joerg Moeller as CEO

An accomplished R&D leader and champion of the application of AI to drug discovery


Glenmark Life Sciences inks CDMO supply deal with a Japanese pharma innovator
News | January 19, 2024

Glenmark Life Sciences inks CDMO supply deal with a Japanese pharma innovator

Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator


Torque Pharma reinvents healthcare dynamics with 'Better Together'
News | January 18, 2024

Torque Pharma reinvents healthcare dynamics with 'Better Together'

The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme


Dr. Reddy's Laboratories acquires Preferred A-1 shares of Edity Therapeutics
News | December 30, 2023

Dr. Reddy's Laboratories acquires Preferred A-1 shares of Edity Therapeutics

The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares


CPHI & PMEC India 2023 redefines pharma landscape
News | November 30, 2023

CPHI & PMEC India 2023 redefines pharma landscape

South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries


DxVx plans to make a license-in agreement of OVM-200
News | November 25, 2023

DxVx plans to make a license-in agreement of OVM-200

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK


AstraZeneca launches health-tech business ‘Evinova’
News | November 21, 2023

AstraZeneca launches health-tech business ‘Evinova’

Evinova will operate as a separate health-tech business within AstraZeneca